CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Shares withheld for taxes SVP, GEN COUNSEL & CORP SEC gave up 1,086 shares (to pay taxes)
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $73.27 ($586,165)
- 4 Gift CHIEF OPERATING OFFICER gave 74,000 shares (gift)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 9,997 shares (to pay taxes)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $83.85 ($670,823)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $90.07 ($450,369)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $86.22 ($689,790)
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $86.51 ($692,101)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 6,250 shares at an average $85.11 ($531,963)
- 144 Insider Sale of Securities
Page 10 of 39 · 770 filings